<ul>
    <li>
        Have increased knowledge regarding the
        <ul>
            <li>Latest data on use of non-vitamin K antagonist oral anticoagulants in the setting of cancer-associated thrombosis</li>
        </ul>
    </li>
    <li>
        Have greater competence related to
        <ul>
            <li>Risk assessment for venous thromboembolism (VTE) recurrence in patients with cancer</li>
            <li>Strategies to tailor long-term VTE treatment strategies in patients with cancer</li>
        </ul>
    </li>
</ul>